Korro Bio and Frequency Therapeutics Announce Merger Agreement

Merger to create a Nasdaq-listed genetic medicines company focused on advancing Korro Bio’s wholly owned portfolio of RNA editing programs Lead prog...

July 17, 2023 | Monday | News
Grifols Meets Enrollment Target in Phase 3 Study of Prolastin®-C for Alpha-1-Antitrypsin Deficiency

Target of 339 patients enrolled has been met in the SPARTA clinical trial, designed to evaluate efficacy and safety of two separate weekly doses of Grifo...

July 14, 2023 | Friday | News
InnoCare and ArriVent Announce Clinical Development Collaboration

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases and ArriVent Bi...

July 14, 2023 | Friday | News
Avantor® Inaugurates Expanded Singapore Hub

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, a...

July 13, 2023 | Thursday | News
Silence Therapeutics Earns $4M Milestone Payment from Hansoh Pharma Collaboration

“We are very pleased with the continued progress being made in our Hansoh Pharma collaboration,” said Craig Tooman, President and CEO of Silenc...

July 12, 2023 | Wednesday | News
Cipla Recalls Six Batches of Albuterol Sulfate Inhalation Aerosol due to Container Defect

Sr. No Product Name Batch No Expiry Date 1 Albuterol Sulfate Inhalation Aerosol, 90mcg (200 MI) IB2004...

July 10, 2023 | Monday | News
Carrick Therapeutics collaborates with Arvinas and Pfizer for clinical trial on Samuraciclib and Vepdegestrant combination

Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced a clinical ...

July 07, 2023 | Friday | News
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd

Syngene (or the “Company”) today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharm...

July 05, 2023 | Wednesday | News
Entourage Health Announces International Sale of Bulk Medical Cannabis to Australia

Company also issues Deferred Share Units to Board of Directors as Quarterly Director’s Remuneration Entourage Health Corp. (TSX-V: ENTG) (...

July 05, 2023 | Wednesday | News
Cortexa Makes First Drug Order for Australian Commercial Market

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the resear...

July 05, 2023 | Wednesday | News
Paras Biopharma Enhances Protein Expression in Microbial Systems for Cost-effective Biologics Production

The company is pleased to disclose its advancement of up to 12 g or more / L expression of recombinant protein - fully folded / biologically active in ferm...

July 04, 2023 | Tuesday | News
SK Bioscience-Sanofi Announce Positive Phase II Results for Pneumococcal Vaccine

The 21-valent pneumococcal conjugate vaccine candidate, GBP410 (also known as SP0202), demonstrates positive safety and immunogenicit...

July 04, 2023 | Tuesday | News
Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China

Adds production capacity to further provide customers with highly purified reagents for quality control and testing Major investment at company’s ...

July 04, 2023 | Tuesday | News
Bruker Introduces SciY™ Platform for Digital Transformation in Life Science and Biopharma

SciY is being launched by Bruker’s new Integrated Data Solutions division, in close collaboration with majority-owned software companies Mestrelab Re...

July 03, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close